Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT04568200 · COMPLETED
Trial details
- NCT number
- NCT04568200
- Sponsor
- Peking Union Medical College Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2023-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.